Merinem

Category: Meropenem 1000 mg

Established in 2022, Montrai has built up a solid foundation in pharmaceutical production technologies. We have overlaid this strength with cutting-edge technologies that we have introduced and consolidated, to maximize effect in pinpointing and utilizing drugs by creating a rapid production system

Montrai has introduced multidimensional analysis to select the optimal drugs for development technologies such as these have served as Montrai Labs backbone in launching highly competitive clinical drugs and basic research studies and in out-licensing new drugs for the pharmaceutical seeds.